表达CSFV E2的重组PRRSV疫苗的免疫持续期
本研究评估了重组活病毒载体疫苗rPRRSV-E2在4周龄仔猪中的免疫持续期。免疫仔猪针对PRRSV和CSFV的高水平抗体可维持至23周,在免疫后20周和24周分别对HP-PRRSV和CSFV攻毒均获得完全保护,免疫后24周保护率仍为100%,表明免疫持续期可达5个月。
要点
- rPRRSV-E2免疫仔猪抗体可维持至23周。
- 免疫后20周和24周攻毒均完全保护。
- 免疫后24周保护率仍为100%,免疫持续期达5个月。
核心结论
- rPRRSV-E2的免疫持续期可达5个月。
研究设计与样本
- 4周龄仔猪接种rPRRSV-E2疫苗或细胞培养基,评估免疫持续期。
主要发现
- 所有免疫仔猪产生针对PRRSV和CSFV的高水平抗体,维持至23周。
- 免疫后20周和24周分别对HP-PRRSV和CSFV攻毒,所有免疫猪均获保护。
- 免疫后24周疫苗保护率仍为100%。
临床怎么用
- rPRRSV-E2可提供至少5个月针对HP-PRRSV和CSFV的保护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Classical swine fever virus (CSFV) and Porcine reproductive and respiratory syndrome virus (PRRSV) are both important pathogens which seriously harm the economic swine industry worldwide. We have previously demonstrated that rPRRSV-E2 is a promising live, virus-vectored vaccine that provides 100% protection against highly pathogenic PRRSV (HP-PRRSV) and CSFV. Here, we evaluated the duration of immunity (DOI) of the vaccine strain, rPRRSV-E2. Vaccine or cell culture medium was administered to piglets at 4 weeks of age. All immunized piglets developed high levels of antibodies, which could maintain for up to 23 weeks, against PRRSV and CSFV. All immunized pigs were well protected from the challenge of HP-PRRSV or CSFV at 20 weeks and 24 weeks post vaccination. The vaccine protection rate was still 100% at 24 weeks after immunization. The immune efficacy results showed that the immune duration of rPRRSV-E2 could be up to 5 months.
引用
- Gao F, Jiang Y, Li G, et al. Immune duration of a recombinant PRRSV vaccine expressing E2 of CSFV. Vaccine. 2020. PMID: 33131934. doi:10.1016/j.vaccine.2020.10.057
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。